clarithromycin has been researched along with Splenic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acharya, N; Chattopadhyay, A; Sharma, A; Sharma, K | 1 |
| Graybill, JR; Moreno, F; Valero, G | 1 |
2 other study(ies) available for clarithromycin and Splenic Diseases
| Article | Year |
|---|---|
Splenic granulomas: a rare manifestation of
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Diagnosis, Differential; Ethambutol; Granuloma; Humans; Immunocompromised Host; Male; Mycobacterium avium Complex; Polymerase Chain Reaction; Rifampin; Spleen; Splenic Diseases | 2018 |
Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection.
Topics: Animals; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Skin Diseases, Bacterial; Splenic Diseases | 1994 |